Mauna Kea Technologies
- Home
- Companies
- Mauna Kea Technologies
- Applications
- Microscope System for Drug discovery ...
Microscope System for Drug discovery and development - Chemical & Pharmaceuticals - Pharmaceutical
In this example, the aggregation of magnetic nanoparticles labeled with DiR is monitored in real time. Tumor microvasculature is labeled using FITC-Dextran.
Most popular related searches
drug discovery and development
drug delivery
epilepsy treatment
blood brain
brain barrier
pharmaceutical research
drug treatment
drug target
drug discovery
drug discovery development
Control experiment: non-magnetic nanoparticles do not aggregate during the application of a magnetic field..
Magnetic nanoparticles aggregate during the application of a magnetic field. They aggregate near the tumor vessel wall. No vascular damage is observed.
Videos courtesy of K. T. Al-Jamal, Drug delivery group, Institute of Pharmaceutical Sciences, King`s College London, UK.Article reference: Real-time monitoring of magnetic drug targeting using fibered confocal fluorescence microscopy. Journal of Controlled Release, 10.1016/j.jconrel.2016.07.026Effect drug treatment on tissue vasculature
This video confirms the integrity of the blood-brain barrier after epilepsy treatment.
Stay in the loop!
Select your areas of interest to receive industry updates.